It was proposed that ATO distinctly downregulates Mcl-1 via GSK-3β activation in APL cells; however, this was not the case in non-APL cells, where the additional modulation of the Mcl-1 level was necessary to sensitise non-APL cells to ATO-induced apoptosis [31]. Here, GSK3B is linked to acute promyelocytic leukemia.